A Randomized, Open Label Study Comparing the Effect of CellCept [mycophenolate mofetil] Combined With Low Dose Versus Standard Dose Tacrolimus, and Corticosteroids, on Kidney Function in Renal Transplantation Patients.

Trial Profile

A Randomized, Open Label Study Comparing the Effect of CellCept [mycophenolate mofetil] Combined With Low Dose Versus Standard Dose Tacrolimus, and Corticosteroids, on Kidney Function in Renal Transplantation Patients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Oct 2014

At a glance

  • Drugs Mycophenolate mofetil (Primary) ; Corticosteroids; Tacrolimus
  • Indications Renal transplant rejection
  • Focus Adverse reactions
  • Sponsors Roche
  • Most Recent Events

    • 15 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 19 Feb 2010 Planned end date changed from 1 Dec 2010 to 1 Aug 2011 as reported by ClinicalTrials.gov.
    • 15 May 2009 Additional location identified as USA as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top